Register for Upcoming Webinar on DEC. 8 @ 11AM

2024 China NMPA Bluebook is here:

Medical Device Made-in-China Policy: A Comprehensive Review and Implementation

  • Version
  • Download 25
  • File Size 0.00 KB
  • File Count 1
  • Create Date January 18, 2024
  • Last Updated February 16, 2024

Medical Device Made-in-China Policy: A Comprehensive Review and Implementation

China is re-opening to the world after COVID isolation in 2023. Volume based purchasing and Made-in-China (MIC) policy are becoming more important in the public hospital purchases. This webinar will discuss the ways overseas manufacturers and innovators can shorten time-to-market, reduce cost and increase sales for the increasing significant role of “Made-in-China” policy. The session will also review the key regulatory policies, guideline requirements regarding the policy to understand the requirements, criteria, and benefits. In addition, the different models of made-in-China policy will be discussed. Overseas manufacturers can create a strategy and implementation plan to leverage the “Made-in-China” policy. The process of utilizing in-China contract manufacturing option will be discussed as well.

  • China MedTech Market High level review
  • The background and relevant regulation of Made-in-China (MIC) policy
  • Benefits of operating under MAH
  • Different models and approaches to achieve MIC policy
  • OEM Responsibilities for Registering New Devices under MAH
  • How to choose a CM operating under MAH
  • Key process and steps to establish MIC with contract manufacturer in China
  • The relationship between made-in-China policy with volume-based purchasing
  • Case Study

Attached Files